Global RNAi Technologies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 148943
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 117
  • list Medical Devices

RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.

Scope of the Report:

The worldwide market for RNAi Technologies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the RNAi Technologies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Alnylam Pharmaceuticals

Benitec Biopharma Ltd

Filmtec Corporation

Ionis Pharmaceuticals

Quark Pharmaceuticals Inc.

RXI Pharmaceuticals

Qiagen

Invitrogen

Ambion

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oncology

Ocular disorders

Respiratory disorders

Liver diseases

Other

Market Segment by Applications, can be divided into

Research

Therapeutics

There are 15 Chapters to deeply display the global RNAi Technologies market.

Chapter 1, to describe RNAi Technologies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of RNAi Technologies, with sales, revenue, and price of RNAi Technologies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of RNAi Technologies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, RNAi Technologies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe RNAi Technologies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 RNAi Technologies Introduction

1.2 Market Analysis by Type

1.2.1 Oncology

1.2.2 Ocular disorders

1.2.3 Respiratory disorders

1.2.4 Liver diseases

1.2.5 Other

1.3 Market Analysis by Applications

1.3.1 Research

1.3.2 Therapeutics

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Alnylam Pharmaceuticals

2.1.1 Business Overview

2.1.2 RNAi Technologies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Alnylam Pharmaceuticals RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Benitec Biopharma Ltd

2.2.1 Business Overview

2.2.2 RNAi Technologies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Benitec Biopharma Ltd RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Filmtec Corporation

2.3.1 Business Overview

2.3.2 RNAi Technologies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Filmtec Corporation RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Ionis Pharmaceuticals

2.4.1 Business Overview

2.4.2 RNAi Technologies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ionis Pharmaceuticals RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Quark Pharmaceuticals Inc.

2.5.1 Business Overview

2.5.2 RNAi Technologies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Quark Pharmaceuticals Inc. RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 RXI Pharmaceuticals

2.6.1 Business Overview

2.6.2 RNAi Technologies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 RXI Pharmaceuticals RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Qiagen

2.7.1 Business Overview

2.7.2 RNAi Technologies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Qiagen RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Invitrogen

2.8.1 Business Overview

2.8.2 RNAi Technologies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Invitrogen RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Ambion

2.9.1 Business Overview

2.9.2 RNAi Technologies Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ambion RNAi Technologies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global RNAi Technologies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global RNAi Technologies Sales and Market Share by Manufacturer (2016-2017)

3.2 Global RNAi Technologies Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 RNAi Technologies Manufacturer Market Share in 2017

3.3.2 Top 6 RNAi Technologies Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global RNAi Technologies Market Analysis by Regions

4.1 Global RNAi Technologies Sales, Revenue and Market Share by Regions

4.1.1 Global RNAi Technologies Sales and Market Share by Regions (2013-2018)

4.1.2 Global RNAi Technologies Revenue and Market Share by Regions (2013-2018)

4.2 North America RNAi Technologies Sales and Growth Rate (2013-2018)

4.3 Europe RNAi Technologies Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific RNAi Technologies Sales and Growth Rate (2013-2018)

4.5 South America RNAi Technologies Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa RNAi Technologies Sales and Growth Rate (2013-2018)

5 North America RNAi Technologies by Countries

5.1 North America RNAi Technologies Sales, Revenue and Market Share by Countries

5.1.1 North America RNAi Technologies Sales and Market Share by Countries (2013-2018)

5.1.2 North America RNAi Technologies Revenue and Market Share by Countries (2013-2018)

5.2 United States RNAi Technologies Sales and Growth Rate (2013-2018)

5.3 Canada RNAi Technologies Sales and Growth Rate (2013-2018)

5.4 Mexico RNAi Technologies Sales and Growth Rate (2013-2018)

6 Europe RNAi Technologies by Countries

6.1 Europe RNAi Technologies Sales, Revenue and Market Share by Countries

6.1.1 Europe RNAi Technologies Sales and Market Share by Countries (2013-2018)

6.1.2 Europe RNAi Technologies Revenue and Market Share by Countries (2013-2018)

6.2 Germany RNAi Technologies Sales and Growth Rate (2013-2018)

6.3 UK RNAi Technologies Sales and Growth Rate (2013-2018)

6.4 France RNAi Technologies Sales and Growth Rate (2013-2018)

6.5 Russia RNAi Technologies Sales and Growth Rate (2013-2018)

6.6 Italy RNAi Technologies Sales and Growth Rate (2013-2018)

7 Asia-Pacific RNAi Technologies by Countries

7.1 Asia-Pacific RNAi Technologies Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific RNAi Technologies Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific RNAi Technologies Revenue and Market Share by Countries (2013-2018)

7.2 China RNAi Technologies Sales and Growth Rate (2013-2018)

7.3 Japan RNAi Technologies Sales and Growth Rate (2013-2018)

7.4 Korea RNAi Technologies Sales and Growth Rate (2013-2018)

7.5 India RNAi Technologies Sales and Growth Rate (2013-2018)

7.6 Southeast Asia RNAi Technologies Sales and Growth Rate (2013-2018)

8 South America RNAi Technologies by Countries

8.1 South America RNAi Technologies Sales, Revenue and Market Share by Countries

8.1.1 South America RNAi Technologies Sales and Market Share by Countries (2013-2018)

8.1.2 South America RNAi Technologies Revenue and Market Share by Countries (2013-2018)

8.2 Brazil RNAi Technologies Sales and Growth Rate (2013-2018)

8.3 Argentina RNAi Technologies Sales and Growth Rate (2013-2018)

8.4 Colombia RNAi Technologies Sales and Growth Rate (2013-2018)

9 Middle East and Africa RNAi Technologies by Countries

9.1 Middle East and Africa RNAi Technologies Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa RNAi Technologies Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa RNAi Technologies Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia RNAi Technologies Sales and Growth Rate (2013-2018)

9.3 UAE RNAi Technologies Sales and Growth Rate (2013-2018)

9.4 Egypt RNAi Technologies Sales and Growth Rate (2013-2018)

9.5 Nigeria RNAi Technologies Sales and Growth Rate (2013-2018)

9.6 South Africa RNAi Technologies Sales and Growth Rate (2013-2018)

10 Global RNAi Technologies Market Segment by Type

10.1 Global RNAi Technologies Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global RNAi Technologies Sales and Market Share by Type (2013-2018)

10.1.2 Global RNAi Technologies Revenue and Market Share by Type (2013-2018)

10.2 Oncology Sales Growth and Price

10.2.1 Global Oncology Sales Growth (2013-2018)

10.2.2 Global Oncology Price (2013-2018)

10.3 Ocular disorders Sales Growth and Price

10.3.1 Global Ocular disorders Sales Growth (2013-2018)

10.3.2 Global Ocular disorders Price (2013-2018)

10.4 Respiratory disorders Sales Growth and Price

10.4.1 Global Respiratory disorders Sales Growth (2013-2018)

10.4.2 Global Respiratory disorders Price (2013-2018)

10.5 Liver diseases Sales Growth and Price

10.5.1 Global Liver diseases Sales Growth (2013-2018)

10.5.2 Global Liver diseases Price (2013-2018)

10.6 Other Sales Growth and Price

10.6.1 Global Other Sales Growth (2013-2018)

10.6.2 Global Other Price (2013-2018)

11 Global RNAi Technologies Market Segment by Application

11.1 Global RNAi Technologies Sales Market Share by Application (2013-2018)

11.2 Research Sales Growth (2013-2018)

11.3 Therapeutics Sales Growth (2013-2018)

12 RNAi Technologies Market Forecast (2018-2023)

12.1 Global RNAi Technologies Sales, Revenue and Growth Rate (2018-2023)

12.2 RNAi Technologies Market Forecast by Regions (2018-2023)

12.2.1 North America RNAi Technologies Market Forecast (2018-2023)

12.2.2 Europe RNAi Technologies Market Forecast (2018-2023)

12.2.3 Asia-Pacific RNAi Technologies Market Forecast (2018-2023)

12.2.4 South America RNAi Technologies Market Forecast (2018-2023)

12.2.5 Middle East and Africa RNAi Technologies Market Forecast (2018-2023)

12.3 RNAi Technologies Market Forecast by Type (2018-2023)

12.3.1 Global RNAi Technologies Sales Forecast by Type (2018-2023)

12.3.2 Global RNAi Technologies Market Share Forecast by Type (2018-2023)

12.4 RNAi Technologies Market Forecast by Application (2018-2023)

12.4.1 Global RNAi Technologies Sales Forecast by Application (2018-2023)

12.4.2 Global RNAi Technologies Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure RNAi Technologies Picture

Table Product Specifications of RNAi Technologies

Figure Global Sales Market Share of RNAi Technologies by Types in 2017

Table

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery